FDA Staff Accounts Conflict On Plan B Decision Timeline, GAO Report Finds

Office of New Drugs officials contend they were told the over-the-counter switch application for Barr's emergency contraceptive would be denied following a positive advisory committee review, but Center for Drug Evaluation & Research officials deny the decision was made before the letter was sent.